Optimal sequencing of ibrutinib, idelalisib, and venetoclax in chronic lymphocytic leukemia: results from a multicenter study of 683 patients
Mato, A.R., Hill, B.T., Lamanna, N., Barr, P.M., Ujjani, C.S., Brander, D.M., Howlett, C., Skarbnik, A.P., Cheson, B.D., Zent, C.S., Pu, J.J., Kiselev, P., Foon, K., Lenhart, J., Henick Bachow, S., Winter, A.M., Cruz, A.-L., Claxton, D.F., Goy, A., Daniel, C., Isaac, K., Kennard, K.H., Timlin, C., Fanning, M., Gashonia, L., Yacur, M., Svoboda, J., Schuster, S.J., Nabhan, C.
Published in Annals of oncology (01.05.2017)
Published in Annals of oncology (01.05.2017)
Get full text
Journal Article
Optimal Sequencing of Ibrutinib, Idelalisib, and Venetoclax in Chronic Lymphocytic Leukemia: Results from a Multi-Center Study of 683 Patients
Mato, A R, Hill, B T, Lamanna, N, Barr, P M, Ujjani, C S, Brander, D M, Howlett, C, Skarbnik, A P, Cheson, B D, Zent, C S, Pu, J J, Kiselev, P, Foon, K, Lenhart, J, Henick Bachow, S, Winter, A M, Cruz, A-L, Claxton, D F, Goy, A, Daniel, C, Isaac, K, Kennard, K H, Timlin, C, Fanning, M, Gashonia, L, Yacur, M, Svoboda, J, Schuster, S J, Nabhan, C
Published in Annals of oncology (25.01.2017)
Get full text
Published in Annals of oncology (25.01.2017)
Journal Article